{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:50:50Z","timestamp":1740135050261,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T00:00:00Z","timestamp":1535155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12913-018-3451-9","type":"journal-article","created":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T05:57:57Z","timestamp":1535176677000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A cross-sectional survey of work and income loss consideration among patients with herpes zoster when completing a quality of life questionnaire"],"prefix":"10.1186","volume":"18","author":[{"given":"Kelly D.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan K.","family":"Brenneman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrisann","family":"Newransky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth","family":"Sheffler-Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura K.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Belland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilo J.","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,25]]},"reference":[{"key":"3451_CR1","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.4065\/82.11.1341","volume":"82","author":"BP Yawn","year":"2007","unstructured":"Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82:1341\u20139.","journal-title":"Mayo Clin Proc"},{"key":"3451_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10935-015-0394-3","volume":"36","author":"JM McLaughlin","year":"2015","unstructured":"McLaughlin JM, McGinnis JJ, Tan L, et al. Estimated human and economic burden of four major adult vaccine-preventable diseases in the United States, 2013. J Prim Prev. 2015;36:259\u201373.","journal-title":"J Prim Prev"},{"key":"3451_CR3","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.vaccine.2012.01.045","volume":"30","author":"M Drolet","year":"2012","unstructured":"Drolet M, Levin MJ, Schmader KE, et al. Employment related productivity loss associated with herpes zoster and postherpetic neuralgia: a 6-month prospective study. Vaccine. 2012;30:2047\u201350.","journal-title":"Vaccine"},{"key":"3451_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3111\/13696998.2011.607482","volume":"14","author":"PK Singhal","year":"2011","unstructured":"Singhal PK, Makin C, Pellissier J, et al. Work and productivity loss related to herpes zoster. J Med Econ. 2011;14:639\u201345.","journal-title":"J Med Econ"},{"key":"3451_CR5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/AJP.0b013e3181eef686","volume":"26","author":"M Drolet","year":"2010","unstructured":"Drolet M, Brisson M, Levin MJ, et al. A prospective study of the herpes zoster severity of illness. Clin J Pain. 2010;26:656\u201366.","journal-title":"Clin J Pain"},{"key":"3451_CR6","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1503\/cmaj.091711","volume":"182","author":"M Drolet","year":"2010","unstructured":"Drolet M, Brisson M, Schmader KE, et al. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ. 2010;182:1731\u20136.","journal-title":"CMAJ"},{"key":"3451_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1086\/421942","volume":"39","author":"J Katz","year":"2004","unstructured":"Katz J, Cooper EM, Walther RR, et al. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis. 2004;39:342\u20138.","journal-title":"Clin Infect Dis"},{"key":"3451_CR8","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/AJP.0b013e318065b6c9","volume":"23","author":"KE Schmader","year":"2007","unstructured":"Schmader KE, Sloane R, Pieper C, et al. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain. 2007;23:490\u20136.","journal-title":"Clin J Pain"},{"key":"3451_CR9","unstructured":"Merck & Co. Inc. Zostavax (package insert). Whitehouse Station, NJ; 2011. http:\/\/www.merck.com\/product\/usa\/pi_circulars\/z\/zostavax\/zostavax_pi2.pdf . Accessed 15 Aug 2018."},{"key":"3451_CR10","unstructured":"Advisory Committee on Immunization Practices (US Centers for Disease Control and Prevention). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2008; RR-5. https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr57e0515a1.htm . Accessed 15 Aug 2018."},{"issue":"6","key":"3451_CR11","doi-asserted-by":"publisher","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","volume":"4","author":"K Kawai","year":"2014","unstructured":"Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6):e004833.","journal-title":"BMJ Open"},{"issue":"7","key":"3451_CR12","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/cid\/cir970","volume":"54","author":"KE Schmader","year":"2012","unstructured":"Schmader KE, Levin MJ, Gnann JW Jr, et al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years. Clin Infect Dis. 2012;54(7):922\u20138.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"3451_CR13","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","volume":"20","author":"RP Insinga","year":"2005","unstructured":"Insinga RP, Itzler RF, Pellissier JM, et al. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005;20(8):748\u201353.","journal-title":"J Gen Intern Med"},{"key":"3451_CR14","volume-title":"Employment status of the civilian noninstitutionalized population by age, sex, and race","author":"US Department of Labor Bureau of Labor Statistics","year":"2015","unstructured":"US Department of Labor Bureau of Labor Statistics. Employment status of the civilian noninstitutionalized population by age, sex, and race. Washington DC: US Department of Labor Bureau of Labor Statistics; 2015."},{"key":"3451_CR15","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.1524-4733.2009.00614.x","volume":"13","author":"C Tilling","year":"2010","unstructured":"Tilling C, Krol M, Tsuchiya A, et al. In or out? Income losses in health state valuations: a review. Value Health. 2010;13:298\u2013305.","journal-title":"Value Health"},{"key":"3451_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQoL Group","year":"1990","unstructured":"EuroQoL Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199\u2013208.","journal-title":"Health Policy"},{"key":"3451_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53\u201372.","journal-title":"Health Policy"},{"key":"3451_CR18","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jpain.2005.01.359","volume":"6","author":"G Oster","year":"2005","unstructured":"Oster G, Harding G, Dukes E, et al. Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J Pain. 2005;6:356\u201363.","journal-title":"J Pain"},{"key":"3451_CR19","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1017\/S0266462308080641","volume":"24","author":"T Davidson","year":"2008","unstructured":"Davidson T, Levin LA. Do individuals consider expected income when valuing health states? Int J Technol Assess Health Care. 2008;24:488\u201394.","journal-title":"Int J Technol Assess Health Care"},{"key":"3451_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2165\/00019053-200624040-00009","volume":"24","author":"M Krol","year":"2006","unstructured":"Krol M, Brouwer W, Sendi P. Productivity costs in health-state valuations: does explicit instruction matter? PharmacoEconomics. 2006;24:401\u201314.","journal-title":"PharmacoEconomics"},{"key":"3451_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10198-008-0107-4","volume":"10","author":"J Richardson","year":"2009","unstructured":"Richardson J, Peacock SJ, Iezzi A. Do quality-adjusted life years take account of lost income? Evidence from an Australian survey. Eur J Health Econ. 2009;10:103\u20139.","journal-title":"Eur J Health Econ"},{"key":"3451_CR22","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/hec.971","volume":"14","author":"P Sendi","year":"2005","unstructured":"Sendi P, Brouwer WB. Is silence golden? A test of the incorporation of the effects of ill-health on income and leisure in health state valuations. Health Econ. 2005;14:643\u20137.","journal-title":"Health Econ"},{"key":"3451_CR23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/0272989X09336161","volume":"29","author":"WB Brouwer","year":"2009","unstructured":"Brouwer WB, Grootenboer S, Sendi P. The incorporation of income and leisure in health state valuations when the measure is silent: an empirical inquiry into the sound of silence. Med Decis Mak. 2009;29:503\u201312.","journal-title":"Med Decis Mak"},{"key":"3451_CR24","first-page":"717","volume":"19","author":"DO Meltzer","year":"1999","unstructured":"Meltzer DO, Weckerle CE, Chang LM. Do people consider financial effects in answering quality of life questions. Med Decis Mak. 1999;19:717.","journal-title":"Med Decis Mak"},{"key":"3451_CR25","unstructured":"Tilling C, Krol M, Trichiya A, et al. The impact of losses in income due to illhealth: does the EQ-5D reflect lost earnings? MPRA Paper University Library Munich 29837, 2009. https:\/\/mpra.ub.uni-muenchen.de\/29837\/1\/MPRA_paper_29837.pdf . Accessed 15 Aug 2018."},{"key":"3451_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2165\/11539910-000000000-00000","volume":"30","author":"C Tilling","year":"2012","unstructured":"Tilling C, Krol M, Tsuchiya A, et al. Does the EQ-5D reflect lost earnings? PharmacoEconomics. 2012;30:47\u201361.","journal-title":"PharmacoEconomics"},{"key":"3451_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1524-4733.2008.00406.x","volume":"12","author":"M Krol","year":"2009","unstructured":"Krol M, Sendi P, Brouwer W. Breaking the silence: exploring the potential effects of explicit instructions on incorporating income and leisure in TTO exercises. Value Health. 2009;12:172\u201380.","journal-title":"Value Health"},{"key":"3451_CR28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jval.2013.02.009","volume":"16","author":"T Shiroiwa","year":"2013","unstructured":"Shiroiwa T, Fukuda T, Ikeda S, et al. QALY and productivity loss: empirical evidence for \u201cdouble counting\u201d. Value Health. 2013;16:581\u20137.","journal-title":"Value Health"},{"key":"3451_CR29","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.clinthera.2013.03.009","volume":"35","author":"GW Frederix","year":"2013","unstructured":"Frederix GW, Quadri N, Hovels AM, et al. Utility and work productivity data for economic evaluation of breast cancer therapies in the Netherlands and Sweden. Clin Ther. 2013;35:e1\u20137.","journal-title":"Clin Ther"},{"key":"3451_CR30","volume-title":"Internet, mail, and mixed-mode surveys. The tailored design method","author":"DA Dillman","year":"2009","unstructured":"Dillman DA, Smyth JD, Christian LM. Internet, mail, and mixed-mode surveys. The tailored design method. 3rd ed. Hoboken, NJ: John Wiley & Sons, Inc.; 2009.","edition":"3"},{"key":"3451_CR31","unstructured":"EuroQoL Group. EQ-5D User Guide, version 5.02013. www.euroqol.org . Accessed 17 Mar 2016."},{"key":"3451_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00005650-200503000-00003","volume":"43","author":"JW Shaw","year":"2005","unstructured":"Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005;43:203\u201320.","journal-title":"Med Care"},{"key":"3451_CR33","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676\u201382.","journal-title":"Am J Epidemiol"},{"key":"3451_CR34","volume-title":"HCUP Comorbidity Software: Health Cost and Utilization Project (HCUP)","author":"Agency for Healthcare Research and Quality","year":"2009","unstructured":"Agency for Healthcare Research and Quality. HCUP Comorbidity Software: Health Cost and Utilization Project (HCUP). 2009."},{"key":"3451_CR35","volume-title":"Standard definitions: final dispositions and case codes and outcome rates for surveys","author":"American Association for Public Opinion Research","year":"2008","unstructured":"American Association for Public Opinion Research. Standard definitions: final dispositions and case codes and outcome rates for surveys. Deerfield, IL: American Association for Public Opinion Research; 2008."},{"key":"3451_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/0272989X06297100","volume":"27","author":"J Myers","year":"2007","unstructured":"Myers J, McCabe S, Gohmann S. Quality-of-life assessment when there is a loss of income. Med Decis Mak. 2007;27:27\u201333.","journal-title":"Med Decis Mak"},{"key":"3451_CR37","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1177\/0272989X9901900427","volume":"19","author":"D Melzter","year":"1999","unstructured":"Melzter D, Weckerle CE, Chang LM. Do people consider financial effects in answering quality of life questions? Med Decis Making. 1999;19:517.","journal-title":"Med Decis Making"},{"key":"3451_CR38","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/1471-2334-14-402","volume":"14","author":"A Gater","year":"2014","unstructured":"Gater A, Abetz-Webb L, Carroll S, et al. Burden of herpes zoster in the UK: findings from the zoster quality of life (ZQOL) study. BMC Infect Dis. 2014;14:402.","journal-title":"BMC Infect Dis"},{"key":"3451_CR39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1477-7525-12-92","volume":"12","author":"M Serpell","year":"2014","unstructured":"Serpell M, Gater A, Carroll S, et al. Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the zoster quality of life (ZQOL) study. Health Qual Life Outcomes. 2014;12:92.","journal-title":"Health Qual Life Outcomes"},{"key":"3451_CR40","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/ageing\/afj048","volume":"35","author":"R van Seventer","year":"2006","unstructured":"van Seventer R, Sadosky A, Lucero M, et al. A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia. Age Ageing. 2006;35:132\u20137.","journal-title":"Age Ageing"},{"key":"3451_CR41","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10389-010-0323-0","volume":"18","author":"T Weinke","year":"2010","unstructured":"Weinke T, Edte A, Schmitt S, et al. Impact of herpes zoster and post-herpetic neuralgia on patients\u2019 quality of life: a patient-reported outcomes survey. Z Gesundh Wiss. 2010;18:367\u201374.","journal-title":"Z Gesundh Wiss"},{"key":"3451_CR42","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10389-011-0481-8","volume":"20","author":"K Lukas","year":"2012","unstructured":"Lukas K, Edte A, Bertrand I. The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countries. Z Gesundh Wiss. 2012;20:441\u201351.","journal-title":"Z Gesundh Wiss"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3451-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-018-3451-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-018-3451-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T07:48:03Z","timestamp":1661845683000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-018-3451-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,25]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3451"],"URL":"https:\/\/doi.org\/10.1186\/s12913-018-3451-9","relation":{},"ISSN":["1472-6963"],"issn-type":[{"type":"electronic","value":"1472-6963"}],"subject":[],"published":{"date-parts":[[2018,8,25]]},"assertion":[{"value":"25 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Independent study approval was obtained from the New England Institutional Review Board (reference # 15\u2013133) and a waiver of documentation of informed consent was granted. The mailed study packet informed patients that their consent for participation was implied by returning the completed survey.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KDJ and CJA are employees of Merck & Co., Inc. SSC was an employee of Merck & Co., Inc. at the time the study was conducted but are no longer employed by Merck. CN was a contract employee of Merck & Co., Inc. at the time the study was conducted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"662"}}